These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29237228)

  • 21. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
    Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
    Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug survival for methotrexate in a daily practice cohort of adult patients with severe atopic dermatitis.
    Politiek K; van der Schaft J; Coenraads PJ; de Bruin-Weller MS; Schuttelaar ML
    Br J Dermatol; 2016 Jan; 174(1):201-3. PubMed ID: 26111229
    [No Abstract]   [Full Text] [Related]  

  • 24. Wet-wrap therapy with halometasone cream for severe adult atopic dermatitis.
    Xu W; Li Y; Chen Z; Liu T; Wang S; Li L
    Postgrad Med; 2018 Jun; 130(5):470-476. PubMed ID: 29768078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
    Schmitt J; Abraham S; Trautmann F; Stephan V; Fölster-Holst R; Homey B; Bieber T; Novak N; Sticherling M; Augustin M; Kleinheinz A; Elsner P; Weidinger S; Werfel T
    J Dtsch Dermatol Ges; 2017 Jan; 15(1):49-59. PubMed ID: 27862987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study.
    Du-Thanh A; Merlet S; Maillard H; Bernard P; Joly P; Estève E; Richard MA; Pauwels C; Ingen-Housz-Oro S; Guillot B; Dereure O
    Br J Dermatol; 2011 Dec; 165(6):1337-43. PubMed ID: 21777222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug survival and postdrug survival of first-line immunosuppressive treatments for atopic dermatitis: comparison between methotrexate and cyclosporine.
    Law Ping Man S; Bouzillé G; Beneton N; Safa G; Dupuy A; Droitcourt C
    J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1327-1335. PubMed ID: 29444359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial.
    Goujon C; Viguier M; Staumont-Sallé D; Bernier C; Guillet G; Lahfa M; Ferrier Le Bouedec MC; Cambazard F; Bottigioli D; Grande S; Dahel K; Bérard F; Rabilloud M; Mercier C; Nicolas JF
    J Allergy Clin Immunol Pract; 2018; 6(2):562-569.e3. PubMed ID: 28967549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug survival for ciclosporin A in a long-term daily practice cohort of adult patients with atopic dermatitis.
    van der Schaft J; Politiek K; van den Reek JMPA; Christoffers WA; Kievit W; de Jong EMGJ; Bruijnzeel-Koomen CAFM; Schuttelaar MLA; de Bruin-Weller MS
    Br J Dermatol; 2015 Jun; 172(6):1621-1627. PubMed ID: 25683671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double-blind, placebo-controlled, phase II study.
    Saeki H; Kabashima K; Tokura Y; Murata Y; Shiraishi A; Tamamura R; Randazzo B; Imanaka K
    Br J Dermatol; 2017 Aug; 177(2):419-427. PubMed ID: 28338223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring.
    Fuggle NR; Bragoli W; Mahto A; Glover M; Martinez AE; Kinsler VA
    J Am Acad Dermatol; 2015 Jan; 72(1):108-14. PubMed ID: 25440430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug survival of systemic immunosuppressive treatments for atopic dermatitis in a long-term pediatric cohort.
    Elsgaard S; Danielsen AK; Thyssen JP; Deleuran M; Vestergaard C
    Int J Womens Dermatol; 2021 Dec; 7(5Part B):708-715. PubMed ID: 35028369
    [No Abstract]   [Full Text] [Related]  

  • 33. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
    Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
    Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1).
    Barker J; Hoffmann M; Wozel G; Ortonne JP; Zheng H; van Hoogstraten H; Reich K
    Br J Dermatol; 2011 Nov; 165(5):1109-17. PubMed ID: 21910713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study.
    Guttman-Yassky E; Silverberg JI; Nemoto O; Forman SB; Wilke A; Prescilla R; de la Peña A; Nunes FP; Janes J; Gamalo M; Donley D; Paik J; DeLozier AM; Nickoloff BJ; Simpson EL
    J Am Acad Dermatol; 2019 Apr; 80(4):913-921.e9. PubMed ID: 29410014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt.
    El-Khalawany MA; Hassan H; Shaaban D; Ghonaim N; Eassa B
    Eur J Pediatr; 2013 Mar; 172(3):351-6. PubMed ID: 23229188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of methotrexate and azathioprine as the first-line steroid-sparing immunosuppressive agents in patients with Takayasu's arteritis.
    Kaymaz-Tahra S; Bayindir O; Ince B; Ozdemir İsik O; Kutu ME; Karakas O; Yildirim TD; Ademoglu Z; Ediboglu ED; Uludogan BCE; Ilgin C; Bilge NSY; Kasifoglu T; Akar S; Emmungil H; Onen F; Omma A; Kanitez NA; Yazici A; Cefle A; Inanc M; Aksu K; Keser G; Direskeneli H; Alibaz-Oner F
    Semin Arthritis Rheum; 2024 Jun; 66():152446. PubMed ID: 38669786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation.
    Kawakami T; Soma Y; Morita E; Koro O; Yamamoto S; Nakamura K; Tamaki K; Yajima K; Imaizumi A; Matsunaga R; Murakami N; Kashima M; Mizoguchi M
    Dermatology; 2001; 203(1):32-7. PubMed ID: 11549797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiological and clinical results of longterm treatment of rheumatoid arthritis with methotrexate and azathioprine.
    Kerstens PJ; Boerbooms AM; Jeurissen ME; de Graaf R; Mulder J; van de Putte LB
    J Rheumatol; 2000 May; 27(5):1148-55. PubMed ID: 10813280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial.
    Berth-Jones J; Takwale A; Tan E; Barclay G; Agarwal S; Ahmed I; Hotchkiss K; Graham-Brown RA
    Br J Dermatol; 2002 Aug; 147(2):324-30. PubMed ID: 12174106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.